The polymorphism rs1051730 of CHRNA3 showed a link to the PAD risk in our population, and the strength of this association is increased by CS, thereby confirming a smoking-related SNP-disease association originally discovered in GWAS performed by the GoLEAD and SUMMIT Consortiums [9]. This evidence concerns the gene CHRNA3 and peripheral arterial disease.